Epidemiology of genital warts in female population of Czech Republic

Czech version

Authors: Tomáš Fait ¹; V. Dvořák ²; A. Skřivánek ³; Z. Rokyta ⁴; R. Pilka ⁵
Authors‘ workplace: HPV College, předseda MUDr. J. Ondruš, MIAC ; Gynekologicko-porodnická klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. A. Martan, DrSc. ¹; Centrum ambulantní gynekologie a primární péče Brno, vedoucí lékař MUDr. V. Dvořák ²; G-centrum, s. r. o., Olomouc, vedoucí lékař MUDr. A. Skřivánek ³; Gynekologicko-porodnická klinika LF UK a FN Plzeň, přednosta doc. MUDr. Z. Novotný, CSc. ⁴; Porodnicko-gynekologická klinika FN a LF UP, Olomouc, přednosta prof. MUDr. R. Pilka, Ph. D. ⁵
Published in: Ceska Gynekol 2012; 77(4): 360-363

Overview

Objective:
The aim of study was to evaluate prevalence of genital warts in Czech Republic.

Subject:
Multicentric prospective observation study.

Setting:
HPV College.

Methods:
During 6 month (February 2010 – July 2010) 20 private gynaecological centers in all Czech Republic were counting up the number of genital wart’s cases. Risk factors, therapy and knowledges about genital warts were evaluated.

Results:
There were 637 patients with genital warts in cohort of 70 980 patients. The prevalence of genital warts was 0.89%. The most frequent risk factor was cigarette smoking in 37%. Main strategy for treatment were podophyllin local application and cold knife excision.

Conclusion:
The prevalence of genital warts in our study has shown importance for it’s prevention by rules of safety sex and HPV vaccination against HPV type 6 and 11.

Key words:
genital warts, epidemiology, HPV vaccination, podophyllin.

Sources

1. Castellsagué, X., Cohet, C., Puky-Tintoré, LM., et al. Epidemiology ad cost of treatment of genital warts in Spain. E J Publ Health, 2008, 19, 1, p. 106–116.

2. de Sanjose, S., Cortes, X., Mendez, C., et al. Age at sexual initiation and numer of sexual partners in the female Spanish population. E J Obstet Gynecol Reprod Biol, 2008, 140, p. 234–240.

3. Dee, A., Howell, F., O’Connor, C., et al. Determining the cost of genital warts: a study from Ireland. Sex Transm Infect, 2009, 85(5), p. 402–403.

4. Desai, S., Wetten, SC., Peters, L., et al. Genital warts and cost of care in England. Sex Transm Infect, 2011, 87(6), p. 464–468.

5. Fenton, KA., Lowndes, CM. Recent trends in the epidemiology of STI in the European Union. Sex Trans Infect, 2004, 80, p. 255–263.

6. Hillemans, P., Breugelmans, JG., Geiseking, F., et al. Estimation of the incidence of genital warts an the cost of illness in Germany: a cross-sectional study. BMC Infect Dis, 2008, 8, p. 76–79.

7. Chuang, TY. Condylomata acuminata. An epidemiologic view. J Am Acad Dermatos, 1987, 16(2), p. 376–384.

8. Klavs, I., Grgič-Vitek, M. The burden of genital warts in Slovenia: results from a national probability sample survey. Eurosurveillance, 2008, 13, 45, p. 19032–19035.

9. Koutsky, L. Epidemiology of genital human papillomavirus infekcion. Am J Med, 1997, 102, p. 3–8.

10. Lin, C., Lau, JTF., Ho, KM., et al. Incidence of genital warts among the Hong Kong general adult population. BMC Infect Diseases, 2010, 10, p. 272–277.

11. Ozgul, N., Tuncer, M., Abacioglu, M., Gultekin, M. Estimating prevalence of genital warts in Turkey. Asian Pac J Cancer Prev, 2011, 12 (9), p. 2397–2400.

12. Stefanaki, C., Barkas, G., Valari, M., et al. Condylomata acuminata in children. Pediatr Infect Dis J, 2011, Dec 23, Epub ahead of print

13. Syrjänen, KJ. Annual disease burden due to HPV 6 and 11 infections in Findland. Scand Inf Dis, Suppl 2009, 107, p. 3–32.

14. UK Collaborative Group for HIV and STI Surveillance. A complex picture: HIV and other STI in the United Kingdom. www.hpa.org.uk/web/HPAweb_C

15. Woodhall, SC., Jit, M., Cai, C., et al. Cost of treatment and QALYęs lost due to genital warts: data from the economic evaluation of HPV vaccines in the United Kingdom. Sex Transm Dis, 2009, 36 (8), p. 515–521.